Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer

NCT01199432 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

501

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: 5-FU（intravenous infusion）+epirubicin+cyclophosphamide
DRUG: 5-FU（intravenous bolus）+epirubicin+cyclophosphamide
DRUG: epirubicin+cyclophosphamide

Sponsor

Tao OUYANG